• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

ITOCO INC to Acquire Biotech Protocols and Technology Related to Carbon Credit Generation From ECAPFIN S.A.P.I. DE C.V

Share:

March 15, 2021

ITOCO INC. (OTC PINK:ITMC) is pleased to announce that it has signed a purchase agreement with ECAPFIN S.A.P.I. De C.V. of Domicilio DISTRITO FEDERAL (Mexico City) Mexico, to acquire all the assets of the company which include:

  1. Bio Tech related to the growth and usage of the Nopal Cactus;
  2. Agreements to amalgamate Nopal Cactus Farms and related assets in Mexico and elsewhere for the purpose of creating commercial products including foods, and renewable bio-energy products;
  3. Technical knowledge related to applying for Carbon Credits that relate to Nopal’s unique Carbon reducing properties.

ITOCO will conduct final due diligence on ECAPFIN’s technology and contracts and the parties intend to close the acquisition transaction by June 30, 2021.

“We are very excited by the potential that ECAPFIN’s technology and assets have in the green Bio-Tech space. We plan to leverage the Nopal plant’s unique properties into several strong products that have significant environmental and land reclamation properties,” said Michael Paul, CEO of ITOCO.

Source: Biospace

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Amazon’s PillPack to Integrate with BCBS Massachusetts’ Member AppAmazon’s PillPack to Integrate with BCBS Massachusetts’ Member App
  • Employer-Focused Behavioral Health Startup Lyra Scores $200MEmployer-Focused Behavioral Health Startup Lyra Scores $200M
  • Ciox Health Acquires Biomedical NLP Company MedalCiox Health Acquires Biomedical NLP Company Medal
  • Machine Learning App Scans Faces and Listens to Speech to Quickly Spot StrokesMachine Learning App Scans Faces and Listens to Speech to Quickly Spot Strokes
  • Pfizer pays BioNTech $120M upfront to form mRNA flu vaccine pactPfizer pays BioNTech $120M upfront to form mRNA flu vaccine pact
  • Biodesix Partners with Streck to Support in Vitro Diagnostic (IVD) StrategyBiodesix Partners with Streck to Support in Vitro Diagnostic (IVD) Strategy
  • Mayo Clinic Teams with Google to Employ Healthcare Cloud ComputingMayo Clinic Teams with Google to Employ Healthcare Cloud Computing
  • Marinus Pharmaceuticals Joins the Loulou Foundation in Collaboration on CANDID, a Comprehensive Observational Study in CDKL5 Deficiency DisorderMarinus Pharmaceuticals Joins the Loulou Foundation in Collaboration on CANDID, a Comprehensive Observational Study in CDKL5 Deficiency Disorder

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications